Spasticity after stroke. Epidemiology and optimal treatment

• Published in: Drugs & aging Vol. 9; no. 5; p. 332
• Main Authors: O'Brien, C F, Seeberger, L C, Smith, D B
• Format: Journal Article
• Language: English
• Published: New Zealand 01.11.1996
• Subjects: Cerebrovascular Disorders - complications; Cerebrovascular Disorders - epidemiology; Cerebrovascular Disorders - therapy; Humans; Muscle Spasticity - epidemiology; Muscle Spasticity - etiology; Muscle Spasticity - therapy
• ISSN: 1170-229X
• DOI: 10.2165/00002512-199609050-00004

Spasticity following stroke reflects a spectrum of clinical problems including increased muscle tone, abnormal limb posture, excessive contraction of antagonist muscles and hyperactive cutaneous and tendon reflexes. The prevalence of stroke-related disability in stroke survivors is high, and spasticity may be a significant component of this. Management strategies include a multidisciplinary team approach utilising a variety of rehabilitation techniques. Although some interventions are well tolerated and fairly standardised, older adults may be particularly sensitive to drug treatment-related adverse effects. This article reviews some of the commonly employed interventions, such as oral medications, and some of the newer techniques, such as intrathecal baclofen infusion and botulinum toxin injections. The optimal management of spasticity following stroke in older adults requires careful goal setting and skilful combination of treatment modalities in order to produce the best outcome.